2012
DOI: 10.2147/ijn.s37113
|View full text |Cite
|
Sign up to set email alerts
|

Heparin nanomodification improves biocompatibility and biomechanical stability of decellularized vascular scaffolds

Abstract: Biocompatibility and biomechanical stability are two of the main obstacles limiting the effectiveness of vascular scaffolds. To improve the biomechanical stability and biocompatibility of these scaffolds, we created a heparin-nanomodified acellular bovine jugular vein scaffold by alternating linkage of heparin and dihydroxy-iron via self-assembly. Features of the scaffold were evaluated in vitro and in vivo. Heparin was firmly linked to and formed nanoscale coatings around the fibers of the scaffold, and the a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
25
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(28 citation statements)
references
References 39 publications
2
25
0
Order By: Relevance
“…And at week 12, the amounts obtained for modified and unmodified scaffolds were 11.97 ± 2.48 and 337.53 ± 25.99 μg/mg dry weight, respectively (Fig. 5), being in agreement to previously reported results 36 . There was a significant difference in calcium content between the heparinized and non-heparinized scaffolds at both time points (P < 0.01), indicating the advantage of H-CSVSs for in vivo vascular regeneration.
Figure 5Column graph of calcification behavior of heparinized and non-heparinized silk scaffolds in vivo .
…”
Section: Resultssupporting
confidence: 92%
See 1 more Smart Citation
“…And at week 12, the amounts obtained for modified and unmodified scaffolds were 11.97 ± 2.48 and 337.53 ± 25.99 μg/mg dry weight, respectively (Fig. 5), being in agreement to previously reported results 36 . There was a significant difference in calcium content between the heparinized and non-heparinized scaffolds at both time points (P < 0.01), indicating the advantage of H-CSVSs for in vivo vascular regeneration.
Figure 5Column graph of calcification behavior of heparinized and non-heparinized silk scaffolds in vivo .
…”
Section: Resultssupporting
confidence: 92%
“…To overcome this challenge, heparin, a widely used anticoagulant biopolymer, has been used in numerous vascular engineering applications 8, 23, 35, 36, 50 . To achieve the desired outcome, the heparin must exist at the blood-material interface in an adequate dose for a sufficient period.…”
Section: Resultsmentioning
confidence: 99%
“…As reported previously, the overall patency rate of the acellular small intestinal submucosa (SIS) was 75% (within 48 weeks), the graft rupture rate was 5% (within 21 days), and aneurysmal dilatation was found in 11% of grafts (8). The poor biomechanical stability of the acellular bovine jugular vein scaffolds results in thrombus formation, aneurysm formation, and calcification, limiting the clinical effectiveness of these scaffolds (9)(10)(11). Decellularized porcine saphenous arteries showed limited patency rates of 60% at 1 month and 50% at 3 months (12).…”
mentioning
confidence: 82%
“…The endothelium also plays a direct role in the regulation of the coagulation cascade and thus thrombosis (3). The poor biomechanical stability of the acellular bovine jugular vein scaffolds results in thrombus formation, aneurysm formation, and calcification, limiting the clinical effectiveness of these scaffolds (9)(10)(11). When the cells were seeded onto scaffolds and cultured in a static setting, the seeding efficiencies were approximately 10-25% (5).…”
mentioning
confidence: 99%
“…All fasting for at least 8 h and after that peripheral venous blood samples were collected in the morning from all participants who were still in a recumbent position (Zhu, Zou, Xiong, & Zhang, ). Venous blood (5 mL) was drawn into an EDTA containing tube and then within 30 min the sample was centrifuged at 3000 rpm for 15 min to obtain the serum, which was then stored at −80 °C refrigerator (Tao, Hu, & Wu, ). Serum UA (SUA), total cholesterol (TC), triglycerides (TG), high‐density lipoprotein cholesterol (HDL), low‐density lipoprotein cholesterol (LDL), blood urea nitrogen (BUN), and serum creatinine (Scr) were determined with commercial kits and an automatic blood cell analyzer (Hitachi 747; Hitachi, Tokyo, Japan) at the central laboratory of Taishan Medical University Affiliated Taishan Hospital.…”
Section: Methodsmentioning
confidence: 99%